Antiapoptotic effect of ouabain on human umbilical vein endothelial cells

Lucia Trevisi1, Barbara Visentin, Federico Cusinato

  • 1Dipartimento di Farmacologia ed Anestesiologia, Università di Padova, Padua, Italy.

Insights

Ouabain demonstrates an anti-apoptotic effect on human umbilical vein endothelial cells (HUVEC) by reducing caspase-3 activation. This protective action is mediated through the activation of phosphatidylinositol 3-kinase (PI-3K) and extracellular signal-regulated kinase (ERK) pathways.

Area of Science:

  • Cardiovascular Biology
  • Cell Signaling
  • Apoptosis Research

Background:

  • Caspase-3 activation is a key mediator of apoptosis.
  • Endothelial cell apoptosis contributes to vascular dysfunction.
  • Ouabain's role in endothelial cell apoptosis requires further elucidation.

Purpose of the Study:

  • To investigate the effect of ouabain on caspase-3 activation in human umbilical vein endothelial cells (HUVEC).
  • To elucidate the signaling pathways involved in ouabain's effect on HUVEC apoptosis.

Main Methods:

  • Human umbilical vein endothelial cells (HUVEC) were treated with ouabain under various conditions (serum/FGF deprivation).
  • Caspase-3 activity was measured.
  • Western blotting was used to assess protein phosphorylation (ERK-1/2).
  • Specific inhibitors (wortmannin for PI-3K, PD98059 for ERK) were employed.

Main Results:

  • Ouabain (20 nM) reduced caspase-3 activity in HUVEC deprived of FGF.
  • Ouabain (100 nM) abolished increased caspase-3 activity induced by serum/FGF deprivation.
  • The protective effect of ouabain was prevented by the PI-3K inhibitor wortmannin.
  • Ouabain increased ERK-1/2 phosphorylation in serum-deprived HUVEC.
  • Inhibition of the ERK pathway abrogated ouabain's effect.

Conclusions:

  • Ouabain exhibits an anti-apoptotic effect on HUVEC.
  • This effect is mediated via the activation of phosphatidylinositol 3-kinase (PI-3K) and extracellular signal-regulated kinase (ERK) dependent pathways.